DLin-MC3-DMA
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
PNI 132, an ionizable lipid derived from the patent WO2020252589A developed by Precision Nanosystem, is useful in the formulation of lipid nanoparticles.
| CAS No. | Not available |
| Chemical Name | PNI 132 |
| Synonyms | PNI132, PNI-132 |
| SMILES | CC/C=C\CC1C(CCC1CC(OCC(OCCCCCCCC/C=C\C/C=C\CCCCC)COCCCCCCCC/C=C\C/C=C\CCCCC)=O)OC(C2CCN(CC2)C)=O |
| Formula | C58H101NO6 |
| M.Wt | 908.43 |
| Purity | Not available |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 11.0080 mL | 2.2016 mL | 1.1008 mL |
| 25 mg | 27.5200 mL | 5.5040 mL | 2.7520 mL |
| 50 mg | 55.0400 mL | 11.0080 mL | 5.5040 mL |
| 100 mg | 110.0800 mL | 22.0160 mL | 11.0080 mL |
| 250 mg | 275.2001 mL | 55.0400 mL | 27.5200 mL |
Contact our team with the catalog number and requested quantity.